ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 41

A Fine Bioinformatical Analysis of Lymphocyte Distribution Predicts the Diagnosis of Systemic Autoimmune Diseases

Quentin Simon1, Bénédicte Rouvière1, Tifenn Martin1, Lucas Le Lann1, Alain Saraux1, Valérie Devauchelle-Pensec1, Concepcion Marañón2, Nieves Varela Hernández2, Aleksandra Dufour3, Carlo Chizzolini4, Ellen de Langhe5, Nuria Barbarroja6, Chary Lopez-Pedrera7, Velia Gerl8, Aurelie Degroof9, Julie Ducreux10, Elena Trombetta11, Tianlu Li12, Marta Alarcón-Riquelme13, Christophe Jamin1 and Jacques-Olivier Pers1, 1U1227, Université de Brest, Inserm, Labex IGO, CHU de Brest, Brest, France, 2GENYO, Centre for Genomics and Oncological Research Pfizer, University of Granada, Andalusian Regional Government, Granada, Spain, 3Immunology & Allergy, University Hospital and School of Medicine, Geneva, Switzerland, 4University hospital of Geneva, Geneva, Switzerland, 5Rheumatology, University Hospital KU Leuven, Leuven, Belgium, 6Rheumatology service, IMIBIC/Reina Sofia Hospital/University of Cordoba, Cordoba, Spain, 7IMIBIC/Reina Sofia Hospital/ University of Cordoba, Cordoba, Spain, 8Department of Rheumatology and Clinical Immunology, Charité University Hospital, Berlin, Germany, 9Pôle de Maladies Rhumatismales, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Brussels, Belgium, 10Pôle de pathologies rhumatismales inflammatoires et systémiques, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Brussels, Belgium, 11Laboratorio di Analisi Chimico Cliniche e Microbiologia - Servizio di Citofluorimetria, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Milano, Italy, 12Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain, 13GENYO. Center for Genomics and Oncological Research, Granada, Spain

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: autoimmune diseases, Bioinformatics, diagnosis and lymphocytes

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 5, 2017

Title: B Cell Biology and Targets in Autoimmune Disease Poster

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose : We investigated 194 individuals with SADs (38 primary Sjögren’s syndrome (pSS), 47 rheumatoid arthritis (RA), 46 systemic lupus erythematosus (SLE), 42 systemic sclerosis (SSc) and 21 undifferentiated connective tissue disease (UCTD) patients) and 53 healthy controls (HCs) to determine whether a fine flow cytometry analysis of T and B cell distribution in whole blood could cluster individuals according to disease diagnosis.

Methods: Two flow cytometry panels were designed. The first panel was dedicated to T cells and combined CD57, CD45RA, CD62L, CD27, CD38, CD3, CD4 and CD8 mAbs. The second panel was dedicated to B cells and combined IgD, TACI, CD27, CD5, CD38, CD19 and CD24 mAbs. A classical manual gating strategy and the Flow-clustering without K (FLOCK) investigation, a density-based clustering approach to algorithmically identify relevant cell populations from multiple samples in an unbiased fashion, were used.

Results: The manual gating strategy allows the identification of 17 distinct lymphocyte subsets. The prediction of the different SADs was determined by discriminant function analysis (DFA). No clustering was found. The FLOCK exploration of the merged HCs identifies 85 distinct subsets of lymphocytes used as reference when compared to SADs . The DFA analysis clearly clusters the HCs and the patients according to each SAD (see figure below).

When compared to HCs, the pSS signature was discriminated by an increase in IgDhiCD24hiCD38hiCD27–TACI–CD5hi transitional B cells, and an increase of CD45RA+CD27–CD62Llo/-CD57hi effector CD8+ T cells.

The SLE signature was discriminated by an increase in IgD–CD24loCD38–CD27–TACI+CD5– memory like B cells, an increase in CD45RA–CD62L+CD38hi activated central memory CD4+ T cells.

The RA signature was discriminated by an increase in IgDhiCD24loCD38–CD27–TACI+CD5– unactivated mature naïve B cells and a decrease in CD45RA+CD62L+CD38hi naïve CD8+ T cells.

The SSc signature was discriminated by a decrease in CD45RA+CD62L+CD38hi naïve CD8+ T cells.

Interestingly, patients with UCTD were distributed among the different clusters (28% with HC, 29% with SLE, 29% with SSc, 9% with RA and 5% with pSS clusters).

Conclusion: A fine bioinformatical flow cytometry analysis of T and B cell subsets clusterizes patients and HCs suggesting that each SAD can be associated with abnormal specific phenotypical distributions that could be helpful in the diagnosis.

This work has received support from the EU/EFPIA Innovative Medicines Initiative Joint Undertaking PRECISESADS grant n° 115565.www.precisesads.eu


Disclosure: Q. Simon, EFPIA, 2; B. Rouvière, None; T. Martin, None; L. Le Lann, EFPIA, 2; A. Saraux, None; V. Devauchelle-Pensec, Roche-Chugai provided me tocilizumab for the SEMAPHORER study, 2; C. Marañón, EFPIA, 2; N. Varela Hernández, EFPIA, 2; A. Dufour, EFPIA, 2; C. Chizzolini, EFPIA, 2; E. de Langhe, None; N. Barbarroja, None; C. Lopez-Pedrera, EFPIA, 2; V. Gerl, EFPIA, 2; A. Degroof, EFPIA, 2; J. Ducreux, EFPIA, 2; E. Trombetta, EFPIA, 2; T. Li, EFPIA, 2; M. Alarcón-Riquelme, Genzyme/Sanofi Corporation, 2; C. Jamin, EFPIA, 2; J. O. Pers, EFPIA, 2.

To cite this abstract in AMA style:

Simon Q, Rouvière B, Martin T, Le Lann L, Saraux A, Devauchelle-Pensec V, Marañón C, Varela Hernández N, Dufour A, Chizzolini C, de Langhe E, Barbarroja N, Lopez-Pedrera C, Gerl V, Degroof A, Ducreux J, Trombetta E, Li T, Alarcón-Riquelme M, Jamin C, Pers JO. A Fine Bioinformatical Analysis of Lymphocyte Distribution Predicts the Diagnosis of Systemic Autoimmune Diseases [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/a-fine-bioinformatical-analysis-of-lymphocyte-distribution-predicts-the-diagnosis-of-systemic-autoimmune-diseases/. Accessed September 24, 2023.
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-fine-bioinformatical-analysis-of-lymphocyte-distribution-predicts-the-diagnosis-of-systemic-autoimmune-diseases/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under embargo once the ACR has notified ­­­presenters of their abstract’s acceptance, and cannot be presented at other meetings after this time. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until November 7 at 10:00 AM ET. Journalists with access to embargoed information also cannot release articles before this time.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Permissions and Reprints

For information about abstract permissions and reprints, see ACR Convergence permissions and reprint policies.

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2023 American College of Rheumatology